Windtree Therapeutics Inc at Ladenburg Thalmann R&D Showcase Transcript
Hello, and welcome to the Ladenburg Thalmann R&D Showcase. Our showcase is designed to highlight companies working through the development, clinical, and regulatory processes. Today, we are excited to showcase Windtree Therapeutics, and we'll turn it over to management in a moment.
We would first like to bring your attention to our necessary disclosures. Further, we would like to reiterate this webinar is being recorded. For any questions or concerns, please contact me, Destiny Hance at [email protected]. Without further ado, I would like to hand the floor over to Jeffrey Cohen, Managing Director, Equity Research. Jeff?
Thanks Destiny, and thanks everyone for joining us. Today, we have the management team of Windtree Therapeutics on who's going to be going through their pipeline, which is quite robust and diversified today with you. So thank you for joining us. I'm going to introduce the three management members and then let them
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |